Mesoblast reported 1.31B in Ordinary Share Capital for its fiscal semester ending in June of 2024.


Ordinary Share Capital Change Date
Clinuvel Pharmaceuticals AUD 168.8M 754.23K Jun/2024
Cochlear AUD 1.18B 19.2M Dec/2024
CSL USD 576M 19M Dec/2024
Pacific Edge NZD 294.46M 58K Sep/2024
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Ramsay Health Care AUD 2.27B 19.6M Dec/2024
Sonic Healthcare AUD 4.15B 467K Dec/2024
Starpharma Holdings AUD 240.75M 0 Dec/2024
Telix Pharmaceuticals AUD 334.72M 252.68M Dec/2024